A more recent study [15] that compared serum levels and plasma activity of the DPP4 among patients with T2DM and healthy subjects showed significant higher levels and activity of the DPP4 in those with diabetes than in controls, but only after excluding patients treated with metformin and/or glitazones. Here, DPP4 is linked to type 2 diabetes mellitus.